Free Trial

Nature's Sunshine Products (NATR) Competitors

Nature's Sunshine Products logo
$13.63 -0.30 (-2.15%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$13.60 -0.03 (-0.18%)
As of 02/21/2025 06:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NATR vs. USNA, HLF, NUS, MED, VERU, EL, IPAR, PBH, ELVN, and COLL

Should you be buying Nature's Sunshine Products stock or one of its competitors? The main competitors of Nature's Sunshine Products include USANA Health Sciences (USNA), Herbalife (HLF), Nu Skin Enterprises (NUS), Medifast (MED), Veru (VERU), Estée Lauder Companies (EL), Inter Parfums (IPAR), Prestige Consumer Healthcare (PBH), Enliven Therapeutics (ELVN), and Collegium Pharmaceutical (COLL).

Nature's Sunshine Products vs.

USANA Health Sciences (NYSE:USNA) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, community ranking, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

USANA Health Sciences has a net margin of 6.30% compared to Nature's Sunshine Products' net margin of 3.81%. Nature's Sunshine Products' return on equity of 11.08% beat USANA Health Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
USANA Health Sciences6.30% 10.64% 8.48%
Nature's Sunshine Products 3.81%11.08%7.23%

54.3% of USANA Health Sciences shares are owned by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are owned by institutional investors. 0.3% of USANA Health Sciences shares are owned by insiders. Comparatively, 4.7% of Nature's Sunshine Products shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

USANA Health Sciences currently has a consensus target price of $38.00, indicating a potential upside of 19.32%. Nature's Sunshine Products has a consensus target price of $19.00, indicating a potential upside of 39.40%. Given Nature's Sunshine Products' stronger consensus rating and higher probable upside, analysts plainly believe Nature's Sunshine Products is more favorable than USANA Health Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
USANA Health Sciences
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Nature's Sunshine Products
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, USANA Health Sciences had 9 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 10 mentions for USANA Health Sciences and 1 mentions for Nature's Sunshine Products. Nature's Sunshine Products' average media sentiment score of 1.85 beat USANA Health Sciences' score of 0.08 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
USANA Health Sciences
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral
Nature's Sunshine Products
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

USANA Health Sciences received 233 more outperform votes than Nature's Sunshine Products when rated by MarketBeat users. However, 63.60% of users gave Nature's Sunshine Products an outperform vote while only 60.45% of users gave USANA Health Sciences an outperform vote.

CompanyUnderperformOutperform
USANA Health SciencesOutperform Votes
399
60.45%
Underperform Votes
261
39.55%
Nature's Sunshine ProductsOutperform Votes
166
63.60%
Underperform Votes
95
36.40%

USANA Health Sciences has higher revenue and earnings than Nature's Sunshine Products. USANA Health Sciences is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
USANA Health Sciences$861.97M0.70$63.79M$2.8311.25
Nature's Sunshine Products$445.32M0.57$15.08M$0.8815.49

USANA Health Sciences has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, Nature's Sunshine Products has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500.

Summary

Nature's Sunshine Products beats USANA Health Sciences on 10 of the 18 factors compared between the two stocks.

Get Nature's Sunshine Products News Delivered to You Automatically

Sign up to receive the latest news and ratings for NATR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NATR vs. The Competition

MetricNature's Sunshine ProductsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$251.88M$7.04B$5.77B$8.98B
Dividend YieldN/A2.87%4.78%3.85%
P/E Ratio15.496.1326.4618.82
Price / Sales0.57311.27456.6780.61
Price / Cash8.9667.8344.0437.47
Price / Book1.636.747.634.64
Net Income$15.08M$138.11M$3.18B$245.69M
7 Day Performance-6.06%-2.43%-1.91%-2.66%
1 Month Performance-6.52%-1.91%-0.19%-2.15%
1 Year Performance-23.21%-5.03%16.70%12.90%

Nature's Sunshine Products Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NATR
Nature's Sunshine Products
3.6471 of 5 stars
$13.63
-2.2%
$19.00
+39.4%
-23.3%$251.88M$445.32M15.49850Positive News
USNA
USANA Health Sciences
4.1386 of 5 stars
$31.03
+1.2%
$38.00
+22.5%
-35.3%$591.49M$921.01M10.971,800Upcoming Earnings
Analyst Downgrade
Analyst Revision
News Coverage
HLF
Herbalife
3.4633 of 5 stars
$5.25
-1.8%
$9.90
+88.8%
-1.3%$528.64M$5.06B6.179,200Earnings Report
Analyst Forecast
Options Volume
News Coverage
Gap Down
NUS
Nu Skin Enterprises
3.1216 of 5 stars
$6.49
+3.1%
$6.88
+5.9%
-39.9%$322.82M$1.97B-3.143,700Analyst Revision
MED
Medifast
3.5274 of 5 stars
$15.19
+0.7%
$17.00
+11.9%
-63.6%$166.17M$1.07B23.01870Earnings Report
Analyst Forecast
News Coverage
VERU
Veru
2.705 of 5 stars
$0.57
+3.2%
$4.00
+598.0%
+15.0%$83.89M$16.89M-2.05230Positive News
EL
Estée Lauder Companies
4.6843 of 5 stars
$68.74
+5.7%
$86.00
+25.1%
-51.4%$24.68B$15.18B-35.2562,000Positive News
IPAR
Inter Parfums
3.6009 of 5 stars
$135.31
-0.4%
$159.40
+17.8%
-11.8%$4.33B$1.32B29.04530
PBH
Prestige Consumer Healthcare
4.0929 of 5 stars
$87.29
+0.3%
$92.50
+6.0%
+22.2%$4.31B$1.13B20.44540Positive News
ELVN
Enliven Therapeutics
1.8203 of 5 stars
$21.55
-2.0%
$38.25
+77.5%
+34.9%$1.05BN/A-11.3450
COLL
Collegium Pharmaceutical
3.793 of 5 stars
$30.52
-1.0%
$43.60
+42.9%
-8.3%$984.27M$566.77M13.16210Upcoming Earnings
News Coverage

Related Companies and Tools


This page (NASDAQ:NATR) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners